XOMA Co. (NASDAQ:XOMAP – Get Free Report) announced a quarterly dividend on Wednesday, October 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of 0.5391 per share on Thursday, January 15th. This represents a c) annualized dividend and a yield of 8.0%. The ex-dividend date is Friday, January 2nd.
XOMA Stock Performance
Shares of NASDAQ:XOMAP opened at $26.83 on Wednesday. The business has a 50 day simple moving average of $26.58 and a two-hundred day simple moving average of $26.22. XOMA has a 1 year low of $24.96 and a 1 year high of $30.00.
About XOMA
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Featured Articles
- Five stocks we like better than XOMA
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
